Related Experiment Video
Updated: May 25, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Causal effects of chronic kidney diseases, renal function, and dialysis on sarcopenia: Insights from a Mendelian
Insights
This study found that reduced estimated creatinine-based glomerular filtration rate (eGFRcrea) and dialysis are causally linked to sarcopenia, a condition common in chronic kidney disease patients. These findings highlight key factors contributing to muscle loss in kidney disease.
Area of Science:
- Nephrology
- Geriatrics
- Genetics
Background:
- Sarcopenia is a common complication in patients with chronic kidney disease (CKD), affecting both dialysis and non-dialysis populations.
- Understanding the causal factors of sarcopenia in CKD is crucial for developing targeted interventions.
Purpose of the Study:
- To investigate the causal relationships between CKD, renal function (eGFRcrea and eGFRcys), and dialysis status with sarcopenia.
- To explore the impact of these factors on specific sarcopenia-related traits such as appendicular lean mass and hand grip strength.
Main Methods:
- Utilized a two-sample Mendelian randomization (MR) approach, employing genetic variants from genome-wide association studies (GWAS).
- Instrumental variables included CKD, eGFRcrea, eGFRcys, and dialysis status.
- Sarcopenia traits analyzed were appendicular lean mass (ALM), hand grip strength (HGS), and usual walking pace (UWP).
Main Results:
- A significant causal effect was observed between decreased eGFRcrea and increased risk of low hand grip strength (HGS) and reduced appendicular lean mass (ALM).
- Dialysis was also found to be significantly associated with low HGS.
- No significant causal association was found between eGFRcys or CKD status and sarcopenia.
Conclusions:
- Declines in estimated creatinine-based glomerular filtration rate (eGFRcrea) and undergoing dialysis are causally associated with sarcopenia.
- These findings underscore the importance of monitoring renal function and dialysis status in the context of sarcopenia management in CKD patients.
Objective:
Sarcopenia is prevalent among patients with chronic kidney diseases (CKD) with or without dialysis. This research aims to explore the causal effects of CKD, renal function, and dialysis on sarcopenia.
Materials And Methods:
Instrumental variables including CKD, estimated creatinine-based glomerular filtration rate (eGFRcrea), estimated cystatin C-based GFR (eGFRcys), and dialysis were identified from a comprehensive genome-wide association study (GWAS). Sarcopenia-related traits, including appendicular lean mass (ALM), hand grip strength (HGS; left/right), low HGS (age 60 and above), and usual walking pace (UWP), were obtained from a meta-analysis of GWAS. Analysis was conducted using the two-sample Mendelian randomization (MR) method.
Results:
MR analysis demonstrated that eGFRcrea was significantly associated with a risk of low HGS (OR = 3.33; 95% CI: 1.93 - 5.74; p < 0.001), ALM (OR = 0.32; 95% CI: 0.21 - 0.48; p < 0.001), HGS (left) (OR = 0.64; 95% CI: 0.55 - 0.74; p < 0.001), and HGS (right) (OR = 0.61; 95% CI: 0.52 - 0.71; p < 0.001). The Inverse-Variance-Weighting (IVW) analysis also revealed that dialysis was significantly associated with low HGS (OR = 1.07; 95% CI: 1.02 - 1.11; p = 0.0018). Sensitivity analysis indicated that the MR analysis was reliable. However, IVW analysis revealed that eGFRcys and CKD were not significantly associated with sarcopenia.
Conclusion:
Our study suggests a causal effect of decline eGFRcrea and dialysis on sarcopenia.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Kidney Structure
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hormonal Regulation

